Zepbound vs Wegovy in Denver, CO: Which Weight Loss Injection Fits?
Zepbound vs Wegovy in Denver, CO
Zepbound (tirzepatide) and Wegovy (semaglutide) are both FDA-approved once-weekly injections for chronic weight management. They are related but not identical, and the better choice depends on your health history, goals, tolerance and budget. A TeleSlim Clinic physician can walk through both with you by video, from anywhere in Denver or across Colorado.
Side by side
| Zepbound | Wegovy | |
|---|---|---|
| Active ingredient | Tirzepatide (GIP and GLP-1 receptor agonist) | Semaglutide (GLP-1 receptor agonist) |
| How it is taken | Once-weekly injection | Once-weekly injection |
| Typical dose steps | Starts at 2.5 mg weekly and increases in 2.5 mg steps about every 4 weeks as tolerated; maintenance doses are 5, 10 or 15 mg | Starts at a low dose and increases about every 4 weeks as tolerated toward a 2.4 mg weekly maintenance dose |
| Other approved uses | Moderate-to-severe obstructive sleep apnea in adults with obesity | Lowering the risk of major cardiovascular events in adults with established cardiovascular disease and either obesity or overweight |
| Boxed warning | Thyroid C-cell tumors seen in rodents | Thyroid C-cell tumors seen in rodents |
| Common side effects | Nausea, diarrhea, vomiting, constipation, stomach pain, injection-site reactions | Nausea, diarrhea, vomiting, constipation, stomach pain |
What the research shows
In a head-to-head clinical trial lasting 72 weeks, adults with obesity taking tirzepatide lost more weight on average than adults taking semaglutide. Averages hide wide differences between people, and a larger average does not mean one medicine is better for you. Tolerability, other health conditions, cost and pharmacy availability all matter.
Questions to discuss with your physician
- Do you have heart disease, sleep apnea or other conditions that affect which approved use matters most?
- How have you tolerated stomach-related side effects with other medicines?
- What does your pharmacy have in stock, and what is your monthly budget?
- Do you or a family member have a history of medullary thyroid carcinoma or MEN 2? If so, neither medicine is appropriate.
FAQs
Is Zepbound stronger than Wegovy?
They work differently, and on average tirzepatide produced greater weight loss than semaglutide in a head-to-head trial. Your own response, side effects and goals matter more than an average.
Can I switch from one to the other?
Your physician can discuss switching. Do not change doses or switch medicines on your own.
Can I get either one online in Colorado?
If a Colorado-licensed physician determines a medicine is medically appropriate after a video visit, a prescription can be sent to your pharmacy. Not everyone qualifies.
What it costs to find out
TeleSlim Clinic visits are self-pay: the initial consultation is $99, then $99 per month for physician follow-up, with savings on longer plans. Medication is a separate pharmacy cost, typically about $150 to $450 per month depending on the medicine and dose, and prices change over time. See our cost guide and insurance guide. We do not dispense medication and do not offer compounded GLP-1 medications.
Meet your physician
Dr. Diala Alatassi, MD, DABIM, DABOM, FACP is Chief Medical Officer of TeleSlim Clinic. She is board-certified in Internal Medicine and Obesity Medicine and is licensed to practice in Colorado. All TeleSlim Clinic visits are conducted by video with a board-certified physician.
Request your free consultation to see whether TeleSlim Clinic is a fit for you in Denver or elsewhere in Colorado.
More comparisons: Oral Wegovy vs Foundayo | Wegovy vs Ozempic and Zepbound vs Mounjaro | Phentermine vs Qsymia | Phentermine vs GLP-1 medications | Weight loss injection vs pill. Or see all options on our weight loss medications in Denver page and our online weight loss doctor page for Denver.
This page is general education, not medical advice. Whether a medication is appropriate is a decision made by a physician after an evaluation. Individual results vary.
